Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT
Robert Howard(University College London), Richard Gray(Barnsley Hospital NHS Foundation Trust), Vivek Pattan(NHS Forth Valley), Cornelius Katona(University College London), John Sykes, Valerie H. Curran(Black Country Partnership NHS Foundation Trust), Robert Barber(University of North Texas), Ramin Nilforooshan(University of Surrey), Rosie Bradley, Craig Ritchie(Western General Hospital), Suzanne Reeves(King's College London), Tom Dening(University of Nottingham), Waleed Fawzi(East London NHS Foundation Trust), Renée Romeo(King's College London), Peter Bentham(Queen Elizabeth Hospital Birmingham), Linda Kelly(Merck & Co., Inc., Rahway, NJ, USA (United States)), Pranathi Ramachandra(Cambridgeshire and Peterborough NHS Foundation Trust), Gill Livingston(North East London NHS Foundation Trust), Ejaz Nazir(Shropshire Community Health NHS Trust), Elizabeth Cort(University College London), Ajay Macharouthu(Crichton Royal Hospital), Andrew Sommerlad(Central and North West London NHS Foundation Trust), Chris Fox(University of California, Irvine), Sabu Oomman(Cheshire West and Chester), Emma Harper(MRC Population Health Research Unit), Martín Knapp(London School of Economics and Political Science)
Cited by 10
Related Papers
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
|The Lancet|2024|2.8k
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Plastic waste associated with disease on coral reefs
|Science|2018|844
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
|New England Journal of Medicine|2012|774